Starling Oncology (STLN) Change in Receivables (2021 - 2026)
Analysis
Starling Oncology (STLN) Change in Receivables (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.36 Bn | 89.35 Bn | 15.19 Bn | 954.00 Mn |
| 2 | Tenet Healthcare | 22.02 Bn | 19.85 Bn | 4.45 Bn | 5.00 Mn |
| 3 | Encompass Health | 12.13 Bn | 11.99 Bn | 1.34 Bn | 10.20 Mn |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | -5.55 Mn |
| 5 | Universal Health Services | 10.09 Bn | 9.95 Bn | 3.29 Bn | 14.05 Mn |
| 6 | Ensign | 9.97 Bn | 9.65 Bn | 306.24 Mn | 5.61 Mn |
| 7 | Chemed | 6.93 Bn | 6.89 Bn | 221.47 Mn | -26.18 Mn |
| 8 | Pacs | 6.81 Bn | 6.64 Bn | 338.46 Mn | -13.54 Mn |
| 9 | Concentra Group Holdings Parent | 4.32 Bn | 4.16 Bn | 192.10 Mn | 3.35 Mn |
| 10 | Starling Oncology | 609.95 Mn | 568.85 Mn | 27.17 Mn | 8.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.22 Mn |
| Mar 31, 2026 | -864,000.00 |
| Dec 31, 2025 | -641,000.00 |
| Sep 30, 2025 | 3.98 Mn |
| Jun 30, 2025 | 7.98 Mn |
| Mar 31, 2025 | 985,000.00 |
| Dec 31, 2024 | -6.17 Mn |
| Sep 30, 2024 | 485,000.00 |
| Jun 30, 2024 | -4.74 Mn |
| Mar 31, 2024 | 16.40 Mn |
| Dec 31, 2023 | -4.09 Mn |
| Sep 30, 2023 | 2.08 Mn |
| Jun 30, 2023 | 435,000.00 |
| Mar 31, 2023 | 6.14 Mn |
| Dec 31, 2022 | 5.07 Mn |
| Sep 30, 2022 | 6.02 Mn |
| Jun 30, 2022 | 4.54 Mn |
| Mar 31, 2022 | 4.66 Mn |
| Dec 31, 2021 | -2.00 Mn |
| Sep 30, 2021 | 2.40 Mn |